Mepo for EoE Study

Summary

Mepo for EoE Study is a clinical trial^[1].

Key Facts

• Mepo for EoE Study is in the country of United States^[2].
• Mepo for EoE Study's instance of is recorded as clinical trial^[3].
• Mepo for EoE Study's start time is recorded as +2019-02-28T00:00:00Z^[4].
• Mepo for EoE Study's end time is recorded as +2020-12-31T00:00:00Z^[5].
• Mepo for EoE Study's sponsor is recorded as University of North Carolina at Chapel Hill^[6].
• Mepo for EoE Study's main subject is recorded as esophagitis^[7].
• Mepo for EoE Study's main subject is recorded as eosinophilic esophagitis^[8].
• Mepo for EoE Study's number of participants is recorded as {'unit': '1', 'amount': '+72'}^[9].
• Mepo for EoE Study's title is recorded as A Multi-center, Randomized, Double Blind, Parallel-arm, Placebo Controlled Trial of Mepolizumab for Treatment of Adults and Adolescents With Active Eosinophilic Esophagitis and Dysphagia-predominant Symptoms^[10].
• Mepo for EoE Study's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+16'}^[11].
• Mepo for EoE Study's ClinicalTrials.gov ID is recorded as NCT03656380^[12].
• Mepo for EoE Study's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+75'}^[13].
• Mepo for EoE Study's clinical trial phase is recorded as phase II clinical trial^[14].
• Mepo for EoE Study's research site is recorded as University of North Carolina at Chapel Hill^[15].
• Mepo for EoE Study's research site is recorded as University of Utah Health Care^[16].
• Mepo for EoE Study's research site is recorded as Northwestern University^[17].
• Mepo for EoE Study's research subject recruitment status is recorded as recruiting^[18].
• Mepo for EoE Study's study type is recorded as interventional study^[19].